Chen Chen

Chen Chen is a Director of Healthcare Equity Research at UBS, focusing on biotech and CRO investments. They previously served as Senior Vice President of Healthcare Equity Research at China Great Wall Securities, where they conducted sector research and developed valuation models. Earlier in their career, Chen worked as a Research Scientist at A*STAR, analyzing monoclonal antibodies and biological samples. Chen holds a Ph.D. in Biotechnology from the University of Cambridge, an M.Sc. in Pharmacology from the University of Oxford, and a BSc in Pharmacy from Capital Medical University.